Skip to main content

Diagnosis of Agranulocytosis Following New Use of Anti-epileptic Drugs, Clozapine, and Olanzapine

Basic Details
Date Posted
Status
Complete
Medical Product
carbamazepine
clozapine
lamotrigine
levetiracetam
ofatumumab
olanzapine
topiramate
Health Outcome(s)
agranulocytosis
Description

This report investigated diagnosis of agranulocytosis following new use of several anti-epileptic drugs (AEDs), as well as clozapine and olanzapine. Data from January 1, 2000 to May 31, 2013 from 18 Data Partners contributing to the Mini-Sentinel Distributed Database (MSDD) were included in this request. The request was distributed to Data Partners on April 11, 2014.

Deliverables (2)
Mini-Sentinel Modular Program Report: Diagnosis of Agranulocytosis Following New Use of AEDs, Clozapine, and Olanzapine, Report 1 Mini-Sentinel Modular Program Report: Diagnosis of Agranulocytosis Following New Use of AEDs, Clozapine, and Olanzapine, Report 2
Additional Details
FDA Center
CDER
Time Period
January 1, 2000 - May 31, 2013
Analysis Type
Mini-Sentinel
Population / Cohort
All individuals
Data Sources
Mini-Sentinel Distributed Database (MSDD)